IBIO
Price
$0.83
Change
+$0.03 (+3.75%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
15.67M
LENZ
Price
$41.12
Change
+$0.59 (+1.46%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
1.16B
Interact to see
Advertisement

IBIO vs LENZ

Header iconIBIO vs LENZ Comparison
Open Charts IBIO vs LENZBanner chart's image
iBio
Price$0.83
Change+$0.03 (+3.75%)
Volume$300
Capitalization15.67M
LENZ Therapeutics
Price$41.12
Change+$0.59 (+1.46%)
Volume$1.4K
Capitalization1.16B
IBIO vs LENZ Comparison Chart in %
Loading...
IBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IBIO vs. LENZ commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBIO is a StrongBuy and LENZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (IBIO: $0.80 vs. LENZ: $40.53)
Brand notoriety: IBIO and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IBIO: 32% vs. LENZ: 48%
Market capitalization -- IBIO: $15.67M vs. LENZ: $1.16B
IBIO [@Biotechnology] is valued at $15.67M. LENZ’s [@Biotechnology] market capitalization is $1.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IBIO’s FA Score shows that 1 FA rating(s) are green whileLENZ’s FA Score has 1 green FA rating(s).

  • IBIO’s FA Score: 1 green, 4 red.
  • LENZ’s FA Score: 1 green, 4 red.
According to our system of comparison, LENZ is a better buy in the long-term than IBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IBIO’s TA Score shows that 5 TA indicator(s) are bullish while LENZ’s TA Score has 3 bullish TA indicator(s).

  • IBIO’s TA Score: 5 bullish, 5 bearish.
  • LENZ’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IBIO is a better buy in the short-term than LENZ.

Price Growth

IBIO (@Biotechnology) experienced а -7.75% price change this week, while LENZ (@Biotechnology) price change was -1.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LENZ($1.16B) has a higher market cap than IBIO($15.7M). LENZ has higher P/E ratio than IBIO: LENZ (48.03) vs IBIO (0.65). LENZ YTD gains are higher at: 40.388 vs. IBIO (-67.457). IBIO has higher annual earnings (EBITDA): -15.11M vs. LENZ (-61.87M). LENZ has more cash in the bank: 210M vs. IBIO (4.96M). LENZ has less debt than IBIO: LENZ (1.05M) vs IBIO (3.76M). LENZ has higher revenues than IBIO: LENZ (5M) vs IBIO (375K).
IBIOLENZIBIO / LENZ
Capitalization15.7M1.16B1%
EBITDA-15.11M-61.87M24%
Gain YTD-67.45740.388-167%
P/E Ratio0.6548.031%
Revenue375K5M8%
Total Cash4.96M210M2%
Total Debt3.76M1.05M357%
FUNDAMENTALS RATINGS
IBIO: Fundamental Ratings
IBIO
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IBIOLENZ
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
IBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDEZX15.600.02
+0.13%
PGIM Jennison Global Equity Income Z
BMSRX15.29N/A
N/A
MFS Blended Research Mid Cap Eq R1
FCLZX14.07N/A
N/A
Fidelity Advisor Climate Action Z
GMSRX12.59-0.03
-0.24%
Nationwide Small Cap Index R
TGADX31.38-0.12
-0.38%
Templeton Growth Adv

IBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBIO has been loosely correlated with REPL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IBIO jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBIO
1D Price
Change %
IBIO100%
-1.68%
REPL - IBIO
38%
Loosely correlated
+32.42%
LIANY - IBIO
37%
Loosely correlated
+8.35%
NUVB - IBIO
36%
Loosely correlated
-1.53%
LENZ - IBIO
35%
Loosely correlated
-1.77%
AIM - IBIO
35%
Loosely correlated
-7.03%
More

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with ZYME. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then ZYME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
-1.77%
ZYME - LENZ
44%
Loosely correlated
-1.03%
XNCR - LENZ
44%
Loosely correlated
-0.67%
BEAM - LENZ
42%
Loosely correlated
-2.79%
CRNX - LENZ
42%
Loosely correlated
+6.35%
OCUL - LENZ
41%
Loosely correlated
+0.41%
More